Fiona Lucas

Adenoma surveillance and colorectal cancer incidence: a retrospective, multicentre, cohort study

Wendy Atkin, Kate Wooldrage, Amy Brenner et al. · The Lancet Oncology · 2017 · 245 citations · Full text

Medicine, Oncology, Pathology +17

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease

Kenneth Down, Augustin Amour, Angela M. Deakin et al. · Journal of Medicinal Chemistry · 2015 · 132 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Faecal immunochemical tests versus colonoscopy for post-polypectomy surveillance: an accuracy, acceptability and economic study

Wendy Atkin, Amanda J. Cross, Ines Kralj‐Hans et al. · Health Technology Assessment · 2019 · 128 citations · Full text

Medicine, Oncology, Surgery +17

The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization

Sharon Bingham, Paul Beswick, C. Bountra et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 63 citations

Medicine, Pharmacology, Pharmacotherapy +17

Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors

Paul Beswick, Sharon Bingham, C. Bountra et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 46 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10